C07C 233/13
With the substituted hydrocarbon radical bound to the nitrogen atom of the
Official title: with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
C07C233/13 (With the substituted hydrocarbon radical bound to the nitrogen atom of the) appears on 126 US grants and 107 published applications in this corpus.
Search patents in C07C- Granted patents
- 126
- Published applications
- 107
- Assignees
- 85
- Inventors
- 382
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 6 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 2 |
| 2003 | 3 | 1 |
| 2004 | 1 | 7 |
| 2005 | 2 | 3 |
| 2006 | 4 | 4 |
| 2007 | 4 | 8 |
| 2008 | 2 | 5 |
| 2009 | 2 | 5 |
| 2010 | 5 | 5 |
| 2011 | 5 | 7 |
| 2012 | 6 | 4 |
| 2013 | 2 | 2 |
| 2014 | 6 | 8 |
| 2015 | 4 | 4 |
| 2016 | 6 | 7 |
| 2017 | 7 | 8 |
| 2018 | 1 | 3 |
| 2019 | 2 | 5 |
| 2020 | 4 | 4 |
| 2021 | 4 | 5 |
| 2022 | 2 | 2 |
| 2023 | 2 | 1 |
| 2024 | 1 | 2 |
| 2025 | 2 | 3 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- CB1R receptor blockers with acyclic backbones18 Nov 2025US 12,473,270 B2Yissum Research Development Company of the Hebrew University of Imersualem Ltd.
- Electrolyte, electrochemical device, lithium ion secondary battery, and module8 Apr 2025US 12,272,789 B2Daikin Industries, Ltd.
- Difluoro phenyl amide RIP1 inhibitor29 Oct 2024US 12,129,221 B2Sironax Ltd.
- Adamantylmethylamine derivative and use thereof as pharmaceutical21 Mar 2023US 11,608,313 B2Tohoku University
- Derivatives of sobetirome14 Feb 2023US 11,578,032 B2Oregon Health & Science University
- Electrolyte Additive, Non-Aqueous Electrolyte for Lithium Secondary Battery Including the Same and Lithium Secondary Battery30 Apr 2026US 2026/0121122 A1LG Energy Solution, Ltd.
- Pi3k-alpha inhibitors and methods of use thereof5 Feb 2026US 2026/0035335 A1Relay Therapeutics, Inc.
- Cb1r receptor blockers with acyclic backbones11 Dec 2025US 2025/0376460 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Pi3k-alpha inhibitors and methods of use thereof9 Oct 2025US 2025/0313524 A1Relay Therapeutics, Inc.
- Electrolyte, electrochemical device, lithium ion secondary battery, and module29 May 2025US 2025/0174720 A1Daikin Industries, Ltd.
Most cited
By later US patents
- Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof75US 6,511,990 B1Sloan-Kettering Institute for Cancer Research · 2003
- Anti-inflammatory compounds62US 6,509,369 B2Ortho-McNeil Pharmaceutical, Inc. · 2003
- Difluoroalkane and difluoroalkenylalkane pesticides47US 4,950,666 AFMC Corporation · 1990
- Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases45US 6,071,970 ANPS Pharmaceuticals, Inc. · 2000
- Substituted amides39US 6,972,295 B2Merck & Co., Inc. · 2005